RELAY THERAPEUTICS INC (RLAY)
US75943R1023 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.03M -96.33% | 1.38M -54.46% | 25.546M 1,751.16% | 15.851M -37.95% | 3.586M -77.38% | 20.571M 473.65% | 23.625M 14.85% | 135.55M 473.76% | 336.52M 148.26% | 614.64M 82.65% | 752.28M 22.39% | 930.32M 23.67% | |
| EBITDA YoY % growth | -348.91M -567.77% | -295.15M 15.41% | -367.731M -24.59% | -386.592M -5.13% | -430.079M -11.25% | -492.901M -14.61% | -434.326M 11.88% | -390.048M 10.19% | -186.211M 52.26% | -25.857M 86.11% | 155.23M 700.34% | 271.13M 74.66% | |
| EBIT YoY % growth | -352.84M -532.33% | -299.28M 15.18% | -373M -24.63% | -395.378M -6.00% | -431.518M -9.14% | -443.345M -2.74% | -416.039M 6.16% | -277.021M 33.41% | -108.642M 60.78% | 106.57M 198.09% | 350.55M 228.94% | 450.13M 28.41% | |
| Operating Margin | -11,644.88% | -21,686.96% | -1,460.11% | -2,494.34% | -12,033.41% | -2,155.20% | -1,761.01% | -204.37% | -32.28% | 17.34% | 46.60% | 48.38% | |
| EPS YoY % growth | -3.85 8.39% | -2.60 32.47% | -2.80 -7.69% | -2.57 8.27% | -2.69 -4.66% | -2.64 1.76% | -2.53 4.02% | -1.72 32.26% | -0.82 52.47% | 0.07 108.34% | 0.50 634.63% | 0.88 75.51% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 10.44% | -0.60 3.48% | -0.63 9.33% | -0.65 -2.54% | -0.66 -9.30% |
| Revenue Q2Q % growth | 90.668K | 61.2K -99.39% | 61.2K | 40.8K | 51K -43.75% |
| EBITDA Q2Q % growth | -98.43M 73.23% | -98.94M -11.21% | -99.96M -2.01% | -100.98M -9.48% | -102M -3.63% |
| EBIT Q2Q % growth | -102.74M 72.46% | -106.524M -17.88% | -111.333M -10.50% | -112.814M -17.06% | -114.625M -11.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.63 -16.67% | -0.78 | 0.15 | 19.53% |
| Q2 2024 Q2Q % growth | -0.69 14.81% | -0.75 | 0.06 | 7.69% |
| Q1 2024 Q2Q % growth | -0.62 20.51% | -0.72 | 0.10 | 13.77% |
| Q4 2023 Q2Q % growth | -0.67 -19.64% | -0.74 | 0.07 | 9.82% |
| Q3 2023 Q2Q % growth | -0.54 28.95% | -0.85 | 0.31 | 36.27% |
| Q2 2023 Q2Q % growth | -0.81 -14.08% | -0.83 | 0.02 | 2.64% |
| Q1 2023 Q2Q % growth | -0.78 -36.84% | -0.71 | -0.07 | -10.62% |
| Q4 2022 Q2Q % growth | -0.56 9.68% | -0.72 | 0.16 | 21.82% |
| Q3 2022 Q2Q % growth | -0.76 -15.15% | -0.72 | -0.04 | -5.60% |
| Q2 2022 Q2Q % growth | -0.71 66.19% | -0.64 | -0.07 | -10.74% |
| Q1 2022 Q2Q % growth | -0.57 -21.28% | -0.63 | 0.06 | 9.62% |
| Q4 2021 Q2Q % growth | -0.62 -188.57% | -0.59 | -0.03 | -5.10% |
| Q3 2021 Q2Q % growth | -0.66 -29.41% | -0.65 | -0.01 | -1.33% |
| Q2 2021 Q2Q % growth | -2.10 65.35% | -0.46 | -1.64 | -351.78% |
| Q1 2021 Q2Q % growth | -0.47 | -0.49 | 0.02 | 4.99% |
| Q4 2020 Q2Q % growth | 0.70 | 0.17 | 0.53 | 307.70% |
| Q3 2020 Q2Q % growth | -0.51 | -0.35 | -0.16 | -44.51% |
| Q2 2020 Q2Q % growth | -6.06 | -0.68 | -5.38 | -796.78% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 81.6K | -81.6K | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 81.6K | -81.6K | -100.00% |
| Q1 2024 Q2Q % growth | 10.007M 4,327.88% | 79.336K | 9.928M | 12,513.51% |
| Q4 2023 Q2Q % growth | 25.546M -100.00% | 129.815K | -129.815K | -100.00% |
| Q3 2023 Q2Q % growth | 25.202M 7,312.35% | 375.697K | 24.826M | 6,608.07% |
| Q2 2023 Q2Q % growth | 119K -67.84% | 706.86K | -587.86K | -83.16% |
| Q1 2023 Q2Q % growth | 226K -46.19% | 191.76K | 34.24K | 17.86% |
| Q4 2022 Q2Q % growth | 250K -56.14% | 3.366M | -3.116M | -92.57% |
| Q3 2022 Q2Q % growth | 340K -49.25% | 1.689M | -1.349M | -79.87% |
| Q2 2022 Q2Q % growth | 370K -55.95% | 1.967M | -1.597M | -81.19% |
| Q1 2022 Q2Q % growth | 420K -55.79% | 170.003K | 249.997K | 147.05% |
| Q4 2021 Q2Q % growth | 570K -99.31% | 3.917M | -3.347M | -85.45% |
| Q3 2021 Q2Q % growth | 670K | 109.283K | 560.717K | 513.09% |
| Q2 2021 Q2Q % growth | 840K | 6.8M | -5.96M | -87.65% |
| Q1 2021 Q2Q % growth | 950K | 4.151M | -3.201M | -77.11% |
| Q4 2020 Q2Q % growth | 82.65M | 37.4M | 45.25M | 120.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 18.63% | 0.69% | 13% |
| Revenue | 0% | 11.11% | 53.95% | 52.99% |